Elite Pharms Inc (ELTP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 03-2026 | 03-2025 | 03-2024 | 03-2023 | 03-2022 | |
| Sales | 148,870 | 84,044 | 56,625 | 34,155 | 32,262 |
| Cost of Goods | 73,846 | 43,957 | 30,268 | 17,561 | 17,467 |
| Gross Profit | 75,024 | 40,087 | 26,357 | 16,594 | 14,795 |
| Operating Expenses | 26,757 | 21,444 | 15,836 | 13,479 | 10,191 |
| Operating Income | 49,113 | 19,601 | 10,789 | 3,676 | 5,071 |
| Interest Expense | 397 | 772 | 589 | 1,113 | 192 |
| Other Income | 8,098 | -18,880 | -9,737 | 1,423 | 1,426 |
| Pre-tax Income | 56,815 | -52 | 463 | 3,986 | 6,304 |
| Income Tax | 11,942 | 4,263 | -19,646 | 424 | -1,736 |
| Net Income Continuous | 44,873 | -4,315 | 20,109 | 3,562 | 8,898 |
| Net Income | $44,873 | $-4,315 | $20,109 | $3,562 | $8,898 |
| EPS Basic Total Ops | 0.04 | 0.00 | 0.02 | 0.00 | 0.01 |
| EPS Basic Continuous Ops | 0.04 | 0.00 | 0.02 | 0.00 | 0.01 |
| EPS Diluted Total Ops | 0.03 | 0.00 | 0.02 | 0.00 | 0.01 |
| EPS Diluted Continuous Ops | 0.04 | 0.00 | 0.02 | 0.00 | 0.01 |
| EPS Diluted Before Non-Recurring Items | 0.01 | 0.02 | 0.03 | 0.00 | 0.01 |
| EBITDA(a) | $51,146 | $21,737 | $12,307 | $5,021 | $6,505 |